company background image
CEMI

Chembio Diagnostics NasdaqCM:CEMI Stock Report

Last Price

US$0.87

Market Cap

US$26.3m

7D

-15.5%

1Y

-64.6%

Updated

15 Aug, 2022

Data

Company Financials
CEMI fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance0/6
Financial Health4/6
Dividends0/6

CEMI Stock Overview

Chembio Diagnostics, Inc., together with its subsidiaries, develops, manufactures, and commercializes point-of-care (POC) diagnostic tests that are used to detect or diagnose diseases.

Chembio Diagnostics, Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Chembio Diagnostics
Historical stock prices
Current Share PriceUS$0.87
52 Week HighUS$3.38
52 Week LowUS$0.42
Beta1.65
1 Month Change9.09%
3 Month Change45.00%
1 Year Change-64.63%
3 Year Change-83.74%
5 Year Change-85.85%
Change since IPO-99.43%

Recent News & Updates

Aug 16

Chembio stock rises 13% amid plans to develop rapid test for monkeypox

Chembio Diagnostics (NASDAQ:CEMI) said it is evaluating the potential to develop a monkeypox rapid point-of-care (POC) test. The company added that it is exploring the technical requirements for test development using its technology platforms, DPP, SURE CHECK, and STAT PAK, along with funding partners. "We are in dialogue with leading health organizations at the federal and state level to evaluate the need for a rapid test to detect and diagnose monkeypox. We are assessing the market needs, timing, regulatory pathway and investment required to develop a test," said Chembio's President and CEO Richard Eberly. CEMI +12.64% to $0.98 premarket Aug. 16

Shareholder Returns

CEMIUS Medical EquipmentUS Market
7D-15.5%2.3%3.6%
1Y-64.6%-19.6%-9.6%

Return vs Industry: CEMI underperformed the US Medical Equipment industry which returned -19.1% over the past year.

Return vs Market: CEMI underperformed the US Market which returned -10.2% over the past year.

Price Volatility

Is CEMI's price volatile compared to industry and market?
CEMI volatility
CEMI Average Weekly Movement17.2%
Medical Equipment Industry Average Movement9.4%
Market Average Movement7.7%
10% most volatile stocks in US Market16.9%
10% least volatile stocks in US Market3.2%

Stable Share Price: CEMI is more volatile than 90% of US stocks over the past 3 months, typically moving +/- 17% a week.

Volatility Over Time: CEMI's weekly volatility (17%) has been stable over the past year, but is still higher than 75% of US stocks.

About the Company

FoundedEmployeesCEOWebsite
1985337Richard Eberlyhttps://chembio.com

Chembio Diagnostics, Inc., together with its subsidiaries, develops, manufactures, and commercializes point-of-care (POC) diagnostic tests that are used to detect or diagnose diseases. The company offers tests for COVID-19, HIV and Syphilis, and Zika virus. It also develops tests for malaria, dengue, chikungunya, Chagas, ebola, leishmaniasis, lassa, marburg, leptospirosis, rickettsia, and Burkholderia diseases.

Chembio Diagnostics, Inc. Fundamentals Summary

How do Chembio Diagnostics's earnings and revenue compare to its market cap?
CEMI fundamental statistics
Market CapUS$26.30m
Earnings (TTM)-US$36.08m
Revenue (TTM)US$60.61m

0.4x

P/S Ratio

-0.7x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
CEMI income statement (TTM)
RevenueUS$60.61m
Cost of RevenueUS$50.71m
Gross ProfitUS$9.90m
Other ExpensesUS$45.97m
Earnings-US$36.08m

Last Reported Earnings

Jun 30, 2022

Next Earnings Date

n/a

Earnings per share (EPS)-1.19
Gross Margin16.33%
Net Profit Margin-59.52%
Debt/Equity Ratio96.1%

How did CEMI perform over the long term?

See historical performance and comparison